# US 2026/0159856 A1 · Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0159856 A1
- Document ID: US20260159856A1
- Status: Published application
- Kind: A1
- Application number: 19/537,643
- Filed: 2026-02-12
- Published: 2026-06-11
- Earliest claimed: 2013-07-10
- Assignees: President and Fellows of Harvard College
- Applicants: President and Fellows of Harvard College
- Inventors: George M. Church; Kevin M. Esvelt; Prashant G. Mali
- Web page: https://patentgrep.com/patent/US20260159856A1

## CPC

- C12N 15/907: {in mammalian cells}
- C07K 2/00: Peptides of undefined number of amino acids; Derivatives thereof
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/85: for animal cells
- C12N 2310/3519: Fusion with another nucleic acid
- C12N 2320/33: Alteration of splicing
- C12N 2320/50: Methods for regulating/modulating their activity
- C12N 2800/107: for mammalian
- C12N 2800/40: Systems of functionally co-operating vectors
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N 2810/10: Vectors comprising a non-peptidic targeting moiety
- C12N 2830/00: Vector systems having a special element relevant for transcription
- C12N 2830/34: being a transcription initiation element
- C12N 2999/007: Technological advancements, e.g. new system for producing known virus, cre-lox system for production of transgenic animals
- C12Y 301/00: Hydrolases acting on ester bonds (3.1)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Y: ENZYMES

## Abstract

Methods of modulating expression of a target nucleic acid in a cell are provided including use of multiple orthogonal Cas9 proteins to simultaneously and independently regulate corresponding genes or simultaneously and independently edit corresponding genes.

## Claims

### Claim at position 1

-40. (canceled)

### Claim 41

A method of altering two or more target nucleic acids in a cell comprising
forming within the cell two or more co-localization complexes, with each including a guide RNA, an orthogonal RNA guided DNA binding protein and a target nucleic acid and wherein each orthogonal RNA guided DNA binding protein of the two or more co-localization complexes is orthogonal to each other, and cuts or nicks the target nucleic acid.

### Claim 42 (depends on 41)

The method of claim 41 wherein each orthogonal RNA guided DNA binding protein comprises a nuclease.

### Claim 43 (depends on 41)

The method of claim 41 wherein each orthogonal RNA guided DNA binding protein comprises a nickase.

### Claim 44 (depends on 41)

The method of claim 41 wherein each orthogonal RNA guided DNA binding protein comprises a nuclease or a nickase.

### Claim 45 (depends on 41)

The method of claim 41 wherein the cell comprises a eukaryotic cell.

### Claim 46 (depends on 41)

The method of claim 41 wherein the cell comprises a yeast cell, a plant cell or an animal cell.

### Claim 47 (depends on 41)

The method of claim 41 wherein each guide RNA is between about 10 to about 500 nucleotides.

### Claim 48 (depends on 41)

The method of claim 41 wherein each guide RNA is between about 20 to about 100 nucleotides.

### Claim 49 (depends on 41)

The method of claim 41 wherein each guide RNA is between about 100 to about 500 nucleotides.

### Claim 50 (depends on 41)

The method of claim 41 wherein each guide RNA comprises a crRNA fused to a tracrRNA.

### Claim 51 (depends on 41)

The method of claim 41 wherein the target nucleic acid comprises genomic DNA, mitochondrial DNA, viral DNA, or exogenous DNA.

### Claim 52 (depends on 41)

The method of claim 41 wherein a plurality of target nucleic acids is cut or nicked.

### Claim 53 (depends on 41)

The method of claim 41 wherein each orthogonal RNA guided DNA binding protein comprises an orthogonal Cas9 protein.

### Claim 54 (depends on 41)

The method of claim 41 comprising
introducing into the cell the two or more guide RNAs complementary to the two or more target nucleic acids, and
introducing into the cell orthogonal RNA guided DNA binding proteins.

### Claim 55

An isolated cell comprising
two or more guide RNAs complementary to two or more respective target nucleic acids,
two or more orthogonal RNA guided DNA binding proteins, wherein each of the two or more orthogonal RNA guided DNA binding proteins is of a different species and recognizes a corresponding PAM sequence in a target nucleic acid, and
wherein the cell comprises two or more co-localization complexes with each including a guide RNA, an orthogonal RNA guided DNA binding protein, and a target nucleic acid.

### Claim 56 (depends on 55)

The isolated cell of claim 55 wherein each orthogonal RNA guided DNA binding protein comprises a nuclease.

### Claim 57 (depends on 55)

The isolated cell of claim 55 wherein each orthogonal RNA guided DNA binding protein comprises a nickase.

### Claim 58 (depends on 55)

The isolated cell of claim 55 wherein each orthogonal RNA guided DNA binding protein comprises a nuclease or a nickase.

### Claim 59 (depends on 55)

The isolated cell of claim 55 wherein the cell comprises a eukaryotic cell.

### Claim 60 (depends on 55)

The isolated cell of claim 55 wherein the cell comprises a yeast cell, a plant cell or an animal cell.

### Claim 61 (depends on 55)

The isolated cell of claim 55 wherein each guide RNA is between about 10 to about 500 nucleotides.

### Claim 62 (depends on 55)

The isolated cell of claim 55 wherein each guide RNA is between about 20 to about 100 nucleotides.

### Claim 63 (depends on 55)

The isolated cell of claim 55 wherein each guide RNA is between about 100 to about 500 nucleotides.

### Claim 64 (depends on 55)

The isolated cell of claim 55 wherein each guide RNA comprises a crRNA fused to a tracrRNA.

### Claim 65 (depends on 55)

The isolated cell of claim 55 wherein the target nucleic acid comprises genomic DNA, mitochondrial DNA, viral DNA, or exogenous DNA.

### Claim 66 (depends on 55)

The isolated cell of claim 55 wherein each orthogonal RNA guided DNA binding protein comprises an orthogonal Cas9 protein.

### Claim 67 (depends on 55)

The isolated cell of claim 55 comprising being in culture.
